Literature DB >> 26729493

Evolution of Pseudomonas aeruginosa Antimicrobial Resistance and Fitness under Low and High Mutation Rates.

Gabriel Cabot1, Laura Zamorano1, Bartolomé Moyà1, Carlos Juan1, Alfonso Navas2, Jesús Blázquez3, Antonio Oliver4.   

Abstract

Pseudomonas aeruginosa, a major cause of nosocomial and chronic infections, is considered a paradigm of antimicrobial resistance development. However, the evolutionary trajectories of antimicrobial resistance and the impact of mutator phenotypes remain mostly unexplored. Therefore, whole-genome sequencing (WGS) was performed in lineages of wild-type and mutator (ΔmutS) strains exposed to increasing concentrations of relevant antipseudomonal agents. WGS provided a privileged perspective of the dramatic effect of mutator phenotypes on the accumulation of random mutations, most of which were transitions, as expected. Moreover, a frameshift mutagenic signature, consistent with error-prone DNA polymerase activity as a consequence of SOS system induction, was also seen. This effect was evidenced for all antibiotics tested, but it was higher for fluoroquinolones than for cephalosporins or carbapenems. Analysis of genotype versus phenotype confirmed expected resistance evolution trajectories but also revealed new pathways. Classical mechanisms included multiple mutations leading to AmpC overexpression (ceftazidime), quinolone resistance-determining region (QRDR) mutations (ciprofloxacin), oprD inactivation (meropenem), and efflux pump overexpression (ciprofloxacin and meropenem). Groundbreaking findings included gain-of-function mutations leading to the structural modification of AmpC (ceftazidime), novel DNA gyrase (GyrA) modification (ciprofloxacin), and the alteration of the β-lactam binding site of penicillin-binding protein 3 (PBP3) (meropenem). A further striking finding was seen in the evolution of meropenem resistance, selecting for specific extremely large (>250 kb) genomic deletions providing a growth advantage in the presence of the antibiotic. Finally, fitness and virulence varied within and across evolved antibiotic-resistant populations, but mutator lineages showed a lower biological cost for some antibiotics.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26729493      PMCID: PMC4775977          DOI: 10.1128/AAC.02676-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  49 in total

Review 1.  Pseudomonas aeruginosa: all roads lead to resistance.

Authors:  Elena B M Breidenstein; César de la Fuente-Núñez; Robert E W Hancock
Journal:  Trends Microbiol       Date:  2011-06-12       Impact factor: 17.079

Review 2.  Pseudomonas aeruginosa: new insights into pathogenesis and host defenses.

Authors:  Shaan L Gellatly; Robert E W Hancock
Journal:  Pathog Dis       Date:  2013-03-15       Impact factor: 3.166

3.  Characterization of the polymyxin B resistome of Pseudomonas aeruginosa.

Authors:  Lucía Fernández; Carolina Alvarez-Ortega; Irith Wiegand; Jorge Olivares; Dana Kocíncová; Joseph S Lam; José Luis Martínez; Robert E W Hancock
Journal:  Antimicrob Agents Chemother       Date:  2012-10-15       Impact factor: 5.191

4.  Development of colistin resistance in pmrA-, phoP-, parR- and cprR-inactivated mutants of Pseudomonas aeruginosa.

Authors:  Ji-Young Lee; Eun Seon Chung; In Young Na; Hyunkeun Kim; Dongwoo Shin; Kwan Soo Ko
Journal:  J Antimicrob Chemother       Date:  2014-07-02       Impact factor: 5.790

Review 5.  Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.

Authors:  Philip D Lister; Daniel J Wolter; Nancy D Hanson
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

Review 6.  Nosocomial infections in adult intensive-care units.

Authors:  Jean-Louis Vincent
Journal:  Lancet       Date:  2003-06-14       Impact factor: 79.321

7.  Experimental validation of Haldane's hypothesis on the role of infection as an evolutionary force for Metazoans.

Authors:  Alfonso Navas; Guillermo Cobas; Miguel Talavera; Juan A Ayala; Juan A López; José L Martínez
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-15       Impact factor: 11.205

8.  Pseudomonas Genome Database: improved comparative analysis and population genomics capability for Pseudomonas genomes.

Authors:  Geoffrey L Winsor; David K W Lam; Leanne Fleming; Raymond Lo; Matthew D Whiteside; Nancy Y Yu; Robert E W Hancock; Fiona S L Brinkman
Journal:  Nucleic Acids Res       Date:  2010-10-06       Impact factor: 16.971

9.  Pseudomonas aeruginosa: resistance to the max.

Authors:  Keith Poole
Journal:  Front Microbiol       Date:  2011-04-05       Impact factor: 5.640

10.  The neglected intrinsic resistome of bacterial pathogens.

Authors:  Alicia Fajardo; Nadia Martínez-Martín; María Mercadillo; Juan C Galán; Bart Ghysels; Sandra Matthijs; Pierre Cornelis; Lutz Wiehlmann; Burkhard Tümmler; Fernando Baquero; José L Martínez
Journal:  PLoS One       Date:  2008-02-20       Impact factor: 3.240

View more
  60 in total

1.  Characterization of Hypermutator Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis in Australia.

Authors:  Vanessa E Rees; Deanna S Deveson Lucas; Carla López-Causapé; Yuling Huang; Tom Kotsimbos; Jürgen B Bulitta; Murray C Rees; Adele Barugahare; Anton Y Peleg; Roger L Nation; Antonio Oliver; John D Boyce; Cornelia B Landersdorfer
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

2.  Hypermutator Pseudomonas aeruginosa Exploits Multiple Genetic Pathways To Develop Multidrug Resistance during Long-Term Infections in the Airways of Cystic Fibrosis Patients.

Authors:  C A Colque; A G Albarracín Orio; S Feliziani; R L Marvig; A R Tobares; H K Johansen; S Molin; A M Smania
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

Review 3.  Roles of two-component regulatory systems in antibiotic resistance.

Authors:  Aimee Rp Tierney; Philip N Rather
Journal:  Future Microbiol       Date:  2019-05-08       Impact factor: 3.165

4.  The Essential Role of Hypermutation in Rapid Adaptation to Antibiotic Stress.

Authors:  Heer H Mehta; Amy G Prater; Kathryn Beabout; Ryan A L Elworth; Mark Karavis; Henry S Gibbons; Yousif Shamoo
Journal:  Antimicrob Agents Chemother       Date:  2019-06-24       Impact factor: 5.191

5.  Deciphering the Resistome of the Widespread Pseudomonas aeruginosa Sequence Type 175 International High-Risk Clone through Whole-Genome Sequencing.

Authors:  Gabriel Cabot; Carla López-Causapé; Alain A Ocampo-Sosa; Lea M Sommer; María Ángeles Domínguez; Laura Zamorano; Carlos Juan; Fe Tubau; Cristina Rodríguez; Bartolomé Moyà; Carmen Peña; Luis Martínez-Martínez; Patrick Plesiat; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

6.  Adaptation of Pseudomonas aeruginosa clinical isolates to benzalkonium chloride retards its growth and enhances biofilm production.

Authors:  Tarek El-Banna; Ahmed Abd El-Aziz; Fatma Sonbol; Engy El-Ekhnawy
Journal:  Mol Biol Rep       Date:  2019-04-11       Impact factor: 2.316

7.  Molecular Epidemiology of Mutations in Antimicrobial Resistance Loci of Pseudomonas aeruginosa Isolates from Airways of Cystic Fibrosis Patients.

Authors:  Leonie Greipel; Sebastian Fischer; Jens Klockgether; Marie Dorda; Samira Mielke; Lutz Wiehlmann; Nina Cramer; Burkhard Tümmler
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

8.  Improved bacterial recombineering by parallelized protein discovery.

Authors:  Timothy M Wannier; Akos Nyerges; Helene M Kuchwara; Márton Czikkely; Dávid Balogh; Gabriel T Filsinger; Nathaniel C Borders; Christopher J Gregg; Marc J Lajoie; Xavier Rios; Csaba Pál; George M Church
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-28       Impact factor: 11.205

9.  Dynamics of Mutations during Development of Resistance by Pseudomonas aeruginosa against Five Antibiotics.

Authors:  Yanfang Feng; Martijs J Jonker; Ioannis Moustakas; Stanley Brul; Benno H Ter Kuile
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

10.  Mechanisms of Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa: Results of the GERPA Multicenter Study.

Authors:  Damien Fournier; Romain Carrière; Maxime Bour; Emilie Grisot; Pauline Triponney; Cédric Muller; Jérôme Lemoine; Katy Jeannot; Patrick Plésiat
Journal:  Antimicrob Agents Chemother       Date:  2021-01-20       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.